Top
Security
Historical Summary
Company Profile
Documentation
Inside Information
Other Relevant Information
Notices
Significant participations
Financial Reports
Historic Info.
Trades
Corporate Actions
Analysis
Videos
Gallery

VYTRUS BIOTECH

Trading sesion

28/06/2024 Close

2.4600

Last price

17.50 mill. €

Capitalisation

2.50

Dif.(%)

32.26

% Year 2024

Albert Jané - Óscar Expósito

CEO and Founder

"We revolutionize the dermo-cosmetics industry and take care of the planet with our sustainable biotechnology."

Print RSS Videos Web

Last Trade

Date

28/06/2024

Hour

Last

2.4600

Ref.

2.4000

Dif.(%)

2.50

Volume (Shares)

482

Turnover (€x1000)

1.19

Go to 5-year chart

28/06/2024 15:59:58
Bid			Ask
Orders	Volume	Price	Price	Volume	Orders
1	300	2.4200	2.4600	388	1

Security

Security name

VYTRUS BIOTECH

Ticker

VYT

ISIN

ES0105618005

NIF

A-65118531

Shares Admitted

7.115.100

Nominal

0,01 Euros

Capital Admitted

71.151,00 Euros

Trading

Fixing

Liquidity Provider

GVC GAESCO VALORES, S.V., S.A.

Registered Advisor

GVC GAESCO VALORES, S.V., S.A.

Auditor

RSM SPAIN AUDITORES S.L.P.

Address

SANT GAIET 121, 08221 TERRASSA, BARCELONA

Contact

investors@vytrus.com

Other Issuer shares

Historical Summary

	2022	2023	2024 until 28/06
Capital Admitted (thousands of euros)	71	71	71
Shares (x 1,000)	7,115	7,115	7,115
Period Close Price (euros)	3.4000	1.8600	2.4600
Period Last Price (euros)	3.4000	1.8600	2.4600
Period High Price (euros)	4.0000	3.5000	2.5000
Period Low Price (euros)	2.0600	1.7800	1.8400
Capitalisation (thousands of euros)	24,191	13,234	17,503
Volume (thousands of shares)	541	367	675
Turnover (thousands of euros)	1,765	957	1,540

"Our biotech platform of plant stem cell cultivations creates a new paradigm in dermo-cosmetics: beauty as a consequence of health and not the other way around."

Company Profile

Vytrus Biotech's goal is to be a benchmark in the dermo-cosmetic ingredients sector in innovation and sustainability through our biotechnological platforms of plant stem cell cultures. We promote skin health to improve people's appearance and well-being.

At Vytrus Biotech we develop, produce and market worldwide high value-added active ingredients in the dermo-cosmetic market. Plant stem cell technology has enormous potential not only in dermo-cosmetics but also in other sectors such as veterinary medicine, functional food and pharmaceuticals.

For the first time, technology and nature can be combined in a single product. Vytrus Biotech's biotechnology gives it a competitive advantage over traditional plant extracts. We obtain highly effective, sustainable and safe products, generating savings of more than 99% in natural resources and contributing to the preservation of the planet's biodiversity.

Source: issuer.

RSS Videos Web

Documentation

08/11/2023 17:30 VYTRUS BIOTECH Inside Information: On P&L Avance resultados Tercer trimestre 2023 (428 KB)

Other Relevant Information

31/05/2024 17:15 VYTRUS BIOTECH Other Relevant Information: Significant participations Variación participaciones significativas (132 KB)

27/05/2024 19:42 VYTRUS BIOTECH Other Relevant Information: Operations carried out by management Operaciones con acciones por parte miembros y observadores Consejo de Administración (374 KB)

27/05/2024 17:05 VYTRUS BIOTECH Other Relevant Information: Initial public offerings and public offerings Finalización proceso Ampliación de capital (94 KB)

20/05/2024 16:01 VYTRUS BIOTECH Other Relevant Information: Operations carried out by management Adquisición acciones por parte Observador Consejo de Administración (158 KB)

10/05/2024 14:48 VYTRUS BIOTECH Other Relevant Information: Announcement of general shareholders’ meeting Convocatoria Junta General Ordinaria de Accionistas (172 KB)

02/05/2024 10:47 VYTRUS BIOTECH Other Relevant Information: Other relevant information Anuncio del BORME de la Ampliación de Capital por aportaciones dinerarias con derecho de suscripción preferente (193 KB)

30/04/2024 17:32 VYTRUS BIOTECH Other Relevant Information: Operations carried out by management Adquisición acciones por parte Observador Consejo de Administración (158 KB)

22/04/2024 16:19 VYTRUS BIOTECH Other Relevant Information: Other relevant information Acuerdos adoptados en la Junta General Extraordinaria de Accionistas (250 KB)

17/04/2024 18:42 VYTRUS BIOTECH Other Relevant Information: Operations carried out by management Adquisición acciones por parte Observador Consejo de Administración (163 KB)

03/04/2024 09:37 VYTRUS BIOTECH Other Relevant Information: Yearly financial reports and audit reports Informes financieros anuales 2023 (14 MB)

21/03/2024 18:25 VYTRUS BIOTECH Other Relevant Information: Announcement of general shareholders’ meeting Convocatoria de Junta General Extraordinaria (173 KB)

07/03/2024 12:04 VYTRUS BIOTECH Other Relevant Information: Other relevant information Presentación Webinar Plan Estratégico 2024-2027 (3 MB)

12/02/2024 17:39 VYTRUS BIOTECH Other Relevant Information: Operations carried out by management Ejecución Plan de acciones para directivos (297 KB)

29/01/2024 08:32 VYTRUS BIOTECH Other Relevant Information: Other relevant information Comunicación de obtención premio en India (697 KB)

05/01/2024 10:18 VYTRUS BIOTECH Other Relevant Information: Significant participations Comunicación Participaciones significativas (129 KB)

See more...See less...

20/11/2023 15:47 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (168 KB)

13/11/2023 15:18 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (188 KB)

06/11/2023 14:42 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización programa de recompra de acciones, estabilización y autocartera (173 KB)

30/10/2023 12:59 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización programa de recompra de acciones, estabilización y autocartera (189 KB)

30/10/2023 09:40 VYTRUS BIOTECH Other Relevant Information: Other relevant information Comunicación inicio comercialización directa en Francia (91 KB)

26/10/2023 12:10 VYTRUS BIOTECH Other Relevant Information: Other relevant information Presentación Resultados Primer Semestre 2023 (4 MB)

24/10/2023 18:27 VYTRUS BIOTECH Other Relevant Information: Other relevant information Obtención financiación CDTI para I+D (406 KB)

23/10/2023 18:47 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (166 KB)

20/10/2023 16:05 VYTRUS BIOTECH Other Relevant Information: Half-yearly financial reports and audit reports/limited audit review Informe Corporativo y Estados Financieros semestrales/Revisión limitada de Auditoría (40 MB)

18/10/2023 09:29 VYTRUS BIOTECH Other Relevant Information: Other relevant information Comunicación próxima publicación resultados (93 KB)

09/10/2023 18:26 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (157 KB)

03/10/2023 09:52 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (162 KB)

28/09/2023 19:53 VYTRUS BIOTECH Other Relevant Information: Other relevant information Comunicado obtención Premio Ingrediente cosmético (338 KB)

25/09/2023 12:54 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (161 KB)

18/09/2023 17:33 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Programas de recompra de acciones, estabilización y autocartera (96 KB)

13/07/2023 09:55 VYTRUS BIOTECH Other Relevant Information: Other relevant information Comunicación de obtención premio en Corea del Sur (424 KB)

04/07/2023 09:53 VYTRUS BIOTECH Other Relevant Information: Significant participations Relación de participaciones significativas a 30 de junio de 2023 (128 KB)

28/06/2023 09:32 VYTRUS BIOTECH Other Relevant Information: Other relevant information Acuerdos adoptados en la Junta General Ordinaria de Accionistas del 27 de junio de 2023 (175 KB)

29/05/2023 17:40 VYTRUS BIOTECH Other Relevant Information: Other relevant information Presentación Foro Medcap 2023 (4 MB)

18/05/2023 10:43 VYTRUS BIOTECH Other Relevant Information: Announcement of general shareholders’ meeting Convocatoria de Junta General Ordinaria de Accionistas (162 KB)

12/04/2023 09:41 VYTRUS BIOTECH Other Relevant Information: Other relevant information Presentación del Webinar sobre el modelo de negocio y resultados ejercicio 2022 (4 MB)

28/03/2023 08:18 VYTRUS BIOTECH Other Relevant Information: Yearly financial reports and audit reports Informe corporativo e Informe de Auditoría 2022. Informe sobre estructura y sistema de control (40 MB)

20/02/2023 09:49 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (93 KB)

13/02/2023 11:43 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Nuevo Plan de Recompra de Acciones (96 KB)

23/01/2023 10:25 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (93 KB)

16/01/2023 11:15 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (166 KB)

09/01/2023 10:26 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (171 KB)

05/01/2023 12:12 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (168 KB)

05/01/2023 11:58 VYTRUS BIOTECH Other Relevant Information: Significant participations Participaciones significativas a 31 de diciembre de 2022 (128 KB)

See more...See less...

12/12/2022 16:06 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (170 KB)

05/12/2022 18:17 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización programa de recompra de acciones, estabilización y autocartera Resumen (93 KB)

28/11/2022 13:13 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (167 KB)

21/11/2022 13:24 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (253 KB)

14/11/2022 16:14 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (251 KB)

07/11/2022 15:21 VYTRUS BIOTECH Other Relevant Information: Other relevant information Obtención Premio a ingrediente más innovador en Asia (538 KB)

07/11/2022 15:20 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (257 KB)

02/11/2022 16:25 VYTRUS BIOTECH Other Relevant Information: Other relevant information Concesión Patente en Estados Unidos (172 KB)

02/11/2022 16:24 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (246 KB)

27/10/2022 11:22 VYTRUS BIOTECH Other Relevant Information: Other relevant information Presentación del Webinar sobre el modelo de negocio y resultados Primer semestre 2022 (4 MB)

20/10/2022 18:09 VYTRUS BIOTECH Other Relevant Information: Half-yearly financial reports and audit reports/limited audit review Informe Corporativo semestral y Estados Financieros semestrales/Revisión Limitada de Auditoría (16 MB)

17/10/2022 10:46 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (256 KB)

10/10/2022 17:02 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización del Programa de recompra de acciones, estabilización y autocartera (253 KB)

03/10/2022 18:19 VYTRUS BIOTECH Other Relevant Information: Other relevant information Comunicado obtención Premio a nivel nacional por un nuevo ingrediente (491 KB)

26/09/2022 12:24 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (240 KB)

23/09/2022 11:52 VYTRUS BIOTECH Other Relevant Information: Other relevant information Obtención del Premio al Ingrediente cosmético más innovador en Latinoamérica (498 KB)

19/09/2022 19:22 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (253 KB)

14/09/2022 17:31 VYTRUS BIOTECH Other Relevant Information: Other relevant information Concesión Patente en Japón (171 KB)

12/09/2022 15:26 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (243 KB)

07/09/2022 16:50 VYTRUS BIOTECH Other Relevant Information: Other relevant information Acuerdos adoptados por la Junta Extraordinaria de Accionistas (310 KB)

05/09/2022 16:20 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (235 KB)

29/08/2022 15:52 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (233 KB)

22/08/2022 09:07 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización del Programa de recompra de acciones, estabilización y autocartera (179 KB)

16/08/2022 09:18 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización del Programa de recompra de acciones, estabilización y autocartera (181 KB)

04/08/2022 19:02 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (176 KB)

01/08/2022 10:58 VYTRUS BIOTECH Other Relevant Information: Announcement of general shareholders’ meeting Convocatoria de Junta General Extraordinaria de Accionistas (269 KB)

01/08/2022 10:56 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (239 KB)

25/07/2022 09:26 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualizació Programa de recompra de acciones, estabilización y autocartera (239 KB)

18/07/2022 09:41 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización programa de recompra de acciones, estabilización y autocartera (240 KB)

11/07/2022 12:43 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programa de recompra de acciones, estabilización y autocartera (241 KB)

08/07/2022 09:55 VYTRUS BIOTECH Other Relevant Information: Significant participations Participaciones significativas a 30 de junio de 2022 (209 KB)

04/07/2022 13:59 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programas de recompra de acciones, estabilización y autocartera (239 KB)

29/06/2022 17:19 VYTRUS BIOTECH Other Relevant Information: Other relevant information Acuerdos adoptados por la Junta General Ordinaria de Accionistas (316 KB)

28/06/2022 23:51 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programas de recompra de acciones, estabilización y autocartera (170 KB)Related to Other Relevant Information 27/06/2022 18:20

27/06/2022 18:20 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización Programas de recompra de acciones, estabilización y autocartera Resumen (207 KB)Related to Other Relevant Information 21/06/2022 07:54

21/06/2022 07:54 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Actualización programa de recompra de acciones, estabilización y autocartera (173 KB)Related to Other Relevant Information 05/05/2022 12:00

09/06/2022 19:10 VYTRUS BIOTECH Other Relevant Information: Liquidity and counterparty agreements Contrato P.liquidez (105 KB)

24/05/2022 12:15 VYTRUS BIOTECH Other Relevant Information: Announcement of general shareholders’ meeting Convocatoria JGOA Vytrus Biotech (265 KB)

20/05/2022 13:43 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes comunicado ordenes plan recompra (105 KB)Related to Other Relevant Information 13/05/2022 17:44

19/05/2022 20:39 VYTRUS BIOTECH Other Relevant Information: Other relevant information Gastos Incurridos Incorporación BME Growth (169 KB)

13/05/2022 17:44 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Comunicado ordenes plan de recompra (150 KB)Related to Other Relevant Information 05/05/2022 12:00

05/05/2022 12:00 VYTRUS BIOTECH Other Relevant Information: Share buy-back , stabilisation and treasury stock programmes Programas de recompra de acciones (176 KB)

25/04/2022 19:41 VYTRUS BIOTECH Other Relevant Information: Yearly financial reports and audit reports Informe corporativo e Informe Auditoria 2021. Informe sobre estructura y sistema de control (52 MB)

24/03/2022 16:45 VYTRUS BIOTECH Other Relevant Information: Other relevant information Levantamiento parcial de lock up (244 KB)

See more...See less...

Notices

2024
2022

Significant participations

08/07/2022 09:55 VYTRUS BIOTECH Other Relevant Information: Significant participations Participaciones significativas a 30 de junio de 2022 (209 KB)

Financial Reports

25/04/2022 19:41 VYTRUS BIOTECH Other Relevant Information: Yearly financial reports and audit reports Informe corporativo e Informe Auditoria 2021. Informe sobre estructura y sistema de control (52 MB)

Analysis

2024
2023

GVC Gaesco Analysis - Estimates revision (9 January 2024) (2 MB)

GVC Gaesco Analysis - Fundamental report (24 January 2023) (2 MB)

Video Gallery

VYTRUS
Discovery Meeting Foro Medcap 2023
30 mayo-1 de junio 2023

Vytrus to start trading on BME Growth
15 March 2022

Photo Gallery

To obtain detailed information or information in other formats, please contact BME Market Data at marketdata@grupobme.es or visit the website www.bmemarketdata.es.

The information provided by the different websites of Grupo BME is for internal use only. For any commercial use and/or other usage that involves the redistribution of the information to third parties for a fee, it is required a prior and express permission from BME Market Data. Please contact us at marketdata@grupobme.es.